Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial
Recent cardiovascular outcome trials have shown significant reductions in major cardiovascular (CV) events with glucagon-like peptide (GLP)-1 receptor agonists. Additionally, adjunctive surrogates for cardiova...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Antonino Tuttolomondo, Anna Cirrincione, Alessandra Casuccio, Alessandro Del Cuore, Mario Daidone, Tiziana Di Chiara, Domenico Di Raimondo, Vittoriano Della Corte, Carlo Maida, Irene Simonetta, Stefania Scaglione and Antonio Pinto Tags: Original investigation Source Type: research